• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Soluble urokinase receptor from fibrosarcoma HT-1080 cells.

作者信息

Lau H K, Kim M

机构信息

Division of Hematology, St Michael's Hospital, Toronto, Ontario, Canada.

出版信息

Blood Coagul Fibrinolysis. 1994 Aug;5(4):473-8.

PMID:7841301
Abstract

A soluble form of urokinase-binding protein has been isolated from the human fibrosarcoma cell line HT-1080 and cell lines derived from it. Conditioned media of these cells were collected after overnight incubation under serum-free conditions, and were concentrated and passed through a column of Sepharose 4B to which high-molecular-weight urokinase had been attached. After thorough washing, a polypeptide could be eluted from the column with 1 M acetic acid. This material appeared to be a single band of approximately 60 kDa on SDS polyacrylamide gel. It cross-reacted with commercial antibodies made against urokinase receptor, and could be chemically cross-linked to the amino terminal fragment of urokinase. This material was similar to the urokinase receptor that was cleaved from HT-1080 cells by means of phosphatidylinositol-specific phospholipase C.

摘要

相似文献

1
Soluble urokinase receptor from fibrosarcoma HT-1080 cells.
Blood Coagul Fibrinolysis. 1994 Aug;5(4):473-8.
2
Tumor cell-conditioned medium stimulates expression of the urokinase receptor in vascular endothelial cells.肿瘤细胞条件培养基刺激血管内皮细胞中尿激酶受体的表达。
J Cell Physiol. 1996 Nov;169(2):300-8. doi: 10.1002/(SICI)1097-4652(199611)169:2<300::AID-JCP9>3.0.CO;2-S.
3
Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.来自纤维肉瘤细胞的针对人54000分子量纤溶酶原激活物抑制剂的单克隆抗体——抑制剂中和及一步亲和纯化
Thromb Haemost. 1986 Apr 30;55(2):206-12.
4
Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.
J Biol Chem. 1991 Jan 25;266(3):1926-33.
5
Vitronectin binding to urokinase receptor in human breast cancer.玻连蛋白与人类乳腺癌中尿激酶受体的结合
Clin Cancer Res. 1997 Aug;3(8):1299-308.
6
Urokinase-type plasminogen-activator receptor associates to a cell surface molecule in monocytic cells.
Biochem Biophys Res Commun. 1996 Jul 5;224(1):252-7. doi: 10.1006/bbrc.1996.1016.
7
Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.尿激酶型纤溶酶原激活剂受体与纤维肉瘤细胞的β1和β3整合素相关联:对细胞外基质成分的依赖性。
Cancer Res. 1997 May 1;57(9):1682-9.
8
Supermacroporous cryogel matrix for integrated protein isolation. Immobilized metal affinity chromatographic purification of urokinase from cell culture broth of a human kidney cell line.用于集成蛋白质分离的超大孔冷冻凝胶基质。从人肾细胞系的细胞培养液中固定化金属亲和色谱法纯化尿激酶。
J Chromatogr A. 2006 Jan 20;1103(1):35-42. doi: 10.1016/j.chroma.2005.08.094. Epub 2005 Dec 20.
9
A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.卵巢癌患者腹水中存在一种无配体的可溶性尿激酶受体。
J Clin Invest. 1993 Nov;92(5):2160-7. doi: 10.1172/JCI116817.
10
Proteins spontaneously released by rat insulinoma (RIN) cells are anchored on cell membrane by a glycosyl-phosphatidyl-inositol link and inhibit increased RIN cell adhesion of lymphocytes from type 1 diabetic patients and non-obese diabetic mice in vitro.大鼠胰岛素瘤(RIN)细胞自发释放的蛋白质通过糖基磷脂酰肌醇连接锚定在细胞膜上,并在体外抑制1型糖尿病患者和非肥胖糖尿病小鼠淋巴细胞的RIN细胞黏附增加。
Diabetes Metab. 1996 Dec;22(6):439-50.

引用本文的文献

1
Relating GPI-Anchored Ly6 Proteins uPAR and CD59 to Viral Infection.将 GPI 锚定的 Ly6 蛋白 uPAR 和 CD59 与病毒感染联系起来。
Viruses. 2019 Nov 14;11(11):1060. doi: 10.3390/v11111060.
2
Role of urokinase receptor in tumor progression and development.尿激酶受体在肿瘤演进和发展中的作用。
Theranostics. 2013 Jun 25;3(7):487-95. doi: 10.7150/thno.4218. Print 2013.
3
Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies.从人癌细胞释放的可溶性尿激酶受体:异种移植肿瘤研究的血浆参数
Br J Cancer. 1999 Sep;81(2):203-11. doi: 10.1038/sj.bjc.6690678.
4
Increase of a urokinase receptor-related low-molecular-weight molecule in colorectal adenocarcinomas.结直肠癌中尿激酶受体相关低分子量分子的增加。
Clin Exp Metastasis. 1995 Nov;13(6):492-8. doi: 10.1007/BF00118188.